Remove AFIB Remove Electrophysiology Remove Reimbursement
article thumbnail

HRS 2024: Innovation Meets Reality

DAIC

In electrophysiology, innovation is king, but it is often incremental, and it almost always lacks rationale, comprehensive clinical documentation and relevance for hospitals that try to balance the increasing costs of new technology with increasing demand and reimbursement that just can’t keep pace.

article thumbnail

Supercharging the ECG: AI set to Revolutionize the Diagnostic Cardiology Market

DAIC

Inevitably, given its fledgling status, regulation and reimbursement is still playing catch-up, though 2023 saw some important developments in this regard. Another vendor to watch in this space is Israeli start-up CardiaCare, currently developing a ‘world-first’ closed-loop, neuromodulation wearable for the non-invasive treatment for AFib.

AFIB 105